No Data
Net income turning positive for the first time, how should we view Yaoshi Bang (09885.HK) in the future?
As the window for the Federal Reserve to cut interest rates approaches, highly interest rate-sensitive industries such as healthcare are experiencing a positive market outlook. Many authoritative institutions have spoken out, pointing out that healthcare stocks, due to their sensitive response to interest rate changes, are highly likely to stand out and become the darlings of the capital markets under the catalyst of rate cuts. Among them, many stocks with both cost-effectiveness and excellent potential are quietly nurturing rich investment opportunities, waiting for investors to discover. Recently, Pharmacist Assistant, China's largest digital comprehensive service platform for out-of-hospital pharmaceutical industry, released its performance data for the first half of 2024, with the company's revenue continuing to maintain double-digit growth.
Pharmacist Help (9885.HK) released its interim performance: revenue increased by 10.6% year-on-year, and net income adjusted for changes also increased by 30.3%.
Pharmacist Help today released the mid-year performance announcement for 2024.
Pharmacist Bang turned its mid-term loss into a profit of 21.82 million yuan, and will not pay interim dividends.
On August 26th, Pharmacist Help announced that it had a net profit attributable to shareholders of 21.82 million yuan (RMB) for the six months ended June 30, 2024, compared to a loss of 3.169 billion yuan in the same period last year, turning the loss into a profit with earnings per share of 0.03 yuan. No interim dividend will be distributed.
Express News | YSB Inc - Hy Rev RMB8.81 Bln Vs RMB7.97 Bln
YSB: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024
Following Recent Decline, YSB Inc.'s (HKG:9885) Top Shareholder CEO Buzhen Zhang Sees Holdings Value Drop by 8.0%
No Data
